Organizer(s): Edward J. Pearce, Florent Ginhoux and Ana-Maria Lennon-DuménilDate: April 08 - 12, 2018
Location: Beaver Run Resort, Breckenridge, CO, USA
This Keystone Symposia conference is the eighth in a series of related Keystone Symposia conferences that have played a pivotal role in emphasizing and focusing myeloid cell research. High-throughput approaches are revealing previously unappreciated complexity in myeloid cell development and function. This ninth meeting focuses on addressing these issues at the basic levels of ontogeny and cellular activation, in the areas of niche specialization, cell/cell interactions, tissue repair, regeneration and development, and infectious and neoplastic disease. The goals of the meeting are to bring together interdisciplinary groups of researchers to attempt to reveal areas of research synergy in a rapidly evolving field, and to generate a vision of critical areas of future research on myeloid cells. The meeting includes a focus on disease that will serve to emphasize the medical relevance of myeloid cell research. Emphasis on the application of cutting-edge immunological approaches in omics, imaging and cell biology makes the conference of general interest to scientists working in these areas of basic and clinical research.
Scholarship Deadline: December 7 2017
Discounted Abstract Deadline: December 7 2017
Abstract Deadline: January 9 2018
Discounted Registration Deadline: February 7 2018
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI138575-01
Funding for this conference was made possible (in part) by 1R13AI138575-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.